NCT00869336

Multicenter Study of the Efficacy and Safety of Luliconazole Cream in Tinea Pedis (Athlete's Foot)

Phase 2 Study - A Randomized, Multi-Center, Double-Blind, Placebo-Controlled Duration Finding Study Evaluating the Efficacy and Safety of Two Week and Four Week Once Daily Treatment of Luliconazole Cream 1% in Patients With Tinea Pedis

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 147 (actual)
• Sponsor: Tinea Pharmaceuticals · Industry
• Sex: All
• Age: 12 Years
• Healthy volunteers: Not accepted

Summary

To examine the safety and optimal duration of Luliconazole Cream 1% treatments for 14 days or 28 days to achieve "complete clearance" at 2 weeks post treatment.

Conditions

• Tinea Pedis

Interventions

Type	Name	Description
DRUG	Luliconazole Cream 1% - 2 wks	Topical cream applied daily for 2 weeks
DRUG	Placebo Comparator -2 wks	Placebo cream applied daily for 2 weeks
DRUG	Luliconazole Cream 1% - 4 wks	Topical cream applied daily for 4 weeks
DRUG	Placebo Comparator - 4 wks	Placebo cream applied daily for 4 weeks

Timeline

• Start date: 2009-03-01
• Primary completion: 2009-09-01
• Completion: 2009-09-01
• First posted: 2009-03-26
• Last updated: 2011-06-21

Locations

4 sites across 1 country: United States